Swiss Life Asset Managers, on behalf of a Swiss Life Infrastructure Fund, and Gelsenwasser AG have agreed to acquire Infrareal GmbH, an owner and operator of Behringwerke and Jena life science parks.
Based in Marburg, Germany, Infrareal is the owner and operator of Behringwerke Marburg and Pharmapark Jena industrial parks. Swiss Life Asset Managers and Gelsenwasser will support Infrareal’s investment program over the next 10 years and spearhead management’s efforts in growing best-in-class site operations as well as technical and logistics services for blue-chip life science companies.
Infrareal is well positioned to take advantage of the global growth in pharmaceuticals, projected at 7.4% between 2020 and 2026, whilst drawing on Swiss Life Asset Managers’ experience in managing major infrastructure investments and Gelsenwasser’s expertise in providing utility solutions to industrial clients as well as operating chemical parks.
“We are delighted to add Infrareal to our portfolio. Infrareal is our first investment in life sciences infrastructure, a strategic asset class given its macro tailwinds and importance to the society. We see Infrareal as a high-quality operator in one of the most stable economies globally”, says Christoph Manser, Head Infrastructure Equity at Swiss Life Asset Managers.
“Based on the Gelsenwasser Group's existing industrial footprint, our investment in the Infrareal Group represents another step towards growth in this strategic business area and helps strengthen the Group's competitiveness. We are very much looking forward to working together with the management and customers of Infrareal", says Henning R. Deters, Chief Executive Officer of Gelsenwasser AG.
Infrareal is the owner and operator of two prime life science-focused industrial parks in Marburg and Jena, Germany. Infrareal helps its clients focus on their core manufacturing and R&D competencies, providing them with all-encompassing infrastructure support which includes buildings, utilities, technical services, logistics and IT solutions. With its attractive locations and high-quality asset base, Infrareal is well-positioned to capture the growth in outsourced infrastructure in the life science industry.